Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The cholesterol controversy]

J L Schlienger

    Presse Medicale (Paris, France : 1983)
    |March 11, 1995
    PubMed
    Summary
    This summary is machine-generated.

    Lowering serum cholesterol too much, below 1.6 g/l, may increase overall mortality. The ideal cholesterol range for minimal risk is between 1.6 and 2.2 g/l, forming a J-curve relationship with health outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Increased reverse triiodothyronine is associated with shorter survival in independently-living elderly: the Alsanut study.

    European journal of endocrinology·2008
    Same author

    Complicated sigmoid diverticulitis.

    Romanian journal of internal medicine = Revue roumaine de medecine interne·2007
    Same author

    Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients.

    The Journal of clinical endocrinology and metabolism·2007
    Same author

    [Impact of systemic disease on the pituitary gland].

    Annales d'endocrinologie·2006
    Same author

    ICAPS: a multilevel program to improve physical activity in adolescents.

    Diabetes & metabolism·2006
    Same author

    Circulating procoagulant microparticles in obesity.

    Diabetes & metabolism·2006
    Same journal

    Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    Ethical, legal, and regulatory challenges in AI-based healthcare tools.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    Decision-making for clinicians.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    Beyond one-size-fits-all: Personalising health communication to drive real behaviour change.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    Metacognition and post-decisional processing in clinical decision-making.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    Fast-and-frugal decision trees for clinicians.

    Presse medicale (Paris, France : 1983)·2026
    See all related articles

    Area of Science:

    • Cardiovascular Medicine
    • Metabolic Disorders
    • Epidemiology

    Background:

    • Extensive cholesterol-lowering trials aimed to reduce serum cholesterol below 2 g/l to mitigate atherogenesis.
    • Meta-analyses indicate a potential rise in overall mortality when cholesterol levels drop below 1.6 g/l.

    Discussion:

    • Cholesterol's role as a cardiovascular risk marker diminishes at very low levels (<1.6 g/l), potentially indicating underlying disease.
    • The relationship between cholesterol levels and mortality risk follows a J-curve, with the lowest risk observed between 1.8 and 2 g/l.

    Key Insights:

    • Minimal risk for morbidity and mortality is associated with cholesterol levels within the 1.6 to 2.2 g/l range.
    • Findings on increased risk at lower cholesterol levels do not contradict the benefits of treating hypercholesterolemia.

    Related Experiment Videos

    Outlook:

    • The objective remains to manage hypercholesterolemia effectively, balancing the prevention of coronary artery disease with overall mortality risks.
    • Further research may clarify the complexities of the J-curve phenomenon and its implications for cardiovascular risk stratification.